exonate.com
ExonateA Biopharmaceutical company developing eyedrop treatment for Age Related Macular Degeneration wet AMD using VEGF alternative splicing
http://www.exonate.com/
A Biopharmaceutical company developing eyedrop treatment for Age Related Macular Degeneration wet AMD using VEGF alternative splicing
http://www.exonate.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
0.7 seconds
16x16
The University of Bristol
Meg Joyce
Senate Ho●●●●●●●●●ll Avenue
Br●●ol , Bristol, BS8 1TH
GB
View this contact
The University of Bristol
Meg Joyce
Senate Ho●●●●●●●●●ll Avenue
Br●●ol , Bristol, BS8 1TH
GB
View this contact
Domain Express
Express Domain
50 Canb●●●●●●●rk Road
Kingsto●●●●●●● Thames , Surrey, KT2 6LX
GB
View this contact
BUY YOUR DOMAIN
12
YEARS
3
MONTHS
14
DAYS
TUCOWS DOMAINS INC.
WHOIS : whois.tucows.com
REFERRED : http://domainhelp.opensrs.net
PAGES IN
THIS WEBSITE
16
SSL
EXTERNAL LINKS
28
SITE IP
89.187.86.121
LOAD TIME
0.657 sec
SCORE
6.2
Exonate | exonate.com Reviews
https://exonate.com
A Biopharmaceutical company developing eyedrop treatment for Age Related Macular Degeneration wet AMD using VEGF alternative splicing
exonate.com
Exonate | International conference and meeting representation
http://exonate.com/conferences
Exonate will be represented at the following upcoming meetings:. 1st International Caparica Conference in Splicing 2016, Lisbon, Portugal, September 2016. Exonate representation at the following meetings:. Association for Research in Vision and Ophthalmology (ARVO). Seattle, USA, May 2016. Association for Research In Vision and Ophthalmology (ARVO). Denver, USA, May 2015. Bio-Trinity 2015 European Biopartnering and Investment Conference. London, UK, May 2015. University of Cambridge, UK, March 2014.
Exonate | Targeting VEGF-mediated Tumor Angiogenesis in Cancer Therapy
http://exonate.com/posters
The Association for Research in Vision and Opthamology 2016. Seattle, USA, May 2016. Targeting VEGF-mediated Tumor Angiogenesis in Cancer Therapy. The New York Academy of Sciences, New York, USA, June 2014. 64th Annual Meeting of the British Microcirculation Society. University of Bristol, UK, April 2014. Download Poster “Development of Novel Anti-Angiogenic SRPK1 Inhibitors”. Download Abstract “Development of Novel Anti-Angiogenic SRPK1 Inhibitors”. Dr Jenny Batson awarded the David Meyer Research Prize.
Exonate | Cambridge entrepeneur steers global medtech innovator - Exonate
http://exonate.com/cambridge-entrepeneur-steers-global-medtech-innovator
Cambridge entrepeneur steers global medtech innovator. Cambridge entrepeneur steers global medtech innovator. Cambridge UK life science entrepreneur Dr Catherine Beech is spearheading a truly international startup initially targeting eye disease but with applications in cancer and other disease areas. September 2, 2014. Prostate Cancer could be “switched off” with injection. Will the eyes have it? Dreams are in lap of the Angels. Dr Jenny Batson awarded the David Meyer Research Prize. April 8, 2016.
Exonate | Cookie Policy - Exonate
http://exonate.com/cookie-policy-2
11 Our website uses cookies. 12 By using our website and agreeing to this policy, you consent to our use of cookies in accordance with the terms of this policy. 21 This document was created using a template from SEQ Legal. Http:/ www.seqlegal.com). 31 A cookie is a file containing an identifier (a string of letters and numbers) that is sent by a web server to a web browser and is stored by the browser. The identifier is then sent back to the server each time the browser requests a page from the server.
Exonate | Exonate | Biotech targeting ophthalmology potentially cancer
http://exonate.com/company
Exonate’s strategy is to exploit its unique ability to alter mRNA splicing to create medicines developed through in-house product development and strategic partnerships. Based on the work of Professor Bates and a deep understanding of the biology of VEGF alternative splicing, Exonate has worked with Professor Jonathan Morris, a chemist at UNSW, to discover a proprietary series of first in class therapeutics, the SPHINXes, and now has a lead candidate under development for the treatment of wet age-related...
TOTAL PAGES IN THIS WEBSITE
16
O2h Ventures
http://www.o2h.com/chemistry.aspx
Seeding Life Science and Technology Innovation. Licensing, Medicinal Chemistry and Investment. In-vivo Pharmacology, Toxicology and Pre-clinical. O2h has extensive capability in computational, analytical and synthetic chemistry and allied scale-up capability.
O2h Ventures
http://www.o2h.com/social-enterprise.aspx
Seeding Life Science and Technology Innovation. Are searching for changemakers with ingenious ideas for our social enterprise incubator. We offer support for business model design, finance, HR, and IT, as well as desk space so you can focus on your venture.
O2h Ventures
http://www.o2h.com/collaborative-discovery.aspx
Seeding Life Science and Technology Innovation. Licensing, Medicinal Chemistry and Investment. In-vivo Pharmacology, Toxicology and Pre-clinical. A collaborative approach to drug discovery enables a wider network of skills, energy and resources to come to together in which the success of the program are shared. O2h can bring to bear and invest its extensive pre-clinical capabilities, medicinal chemistry and licensing skills to share or run an end to end program or project to agreed milestones.
O2h Ventures
http://www.o2h.com/community.aspx
Seeding Life Science and Technology Innovation. Licensing, Medicinal Chemistry and Investment. In-vivo Pharmacology, Toxicology and Pre-clinical. In O2h we have made an-going contribution to working in the community in India for more than a decade. o2h endeavours to give time, energy, care and attention to various NGO organisations and in particular the people they serve. In O2h we have an aspiration to develop a hub for social entrepreneurs in Ahmedabad, India.
O2h Ventures
http://www.o2h.com/collaborators.aspx
Seeding Life Science and Technology Innovation. Licensing, Medicinal Chemistry and Investment. In-vivo Pharmacology, Toxicology and Pre-clinical.
O2h Ventures
http://www.oxygenhealthcare.com/chemistry.aspx
Seeding Life Science and Technology Innovation. Licensing, Medicinal Chemistry and Investment. In-vivo Pharmacology, Toxicology and Pre-clinical. O2h has extensive capability in computational, analytical and synthetic chemistry and allied scale-up capability.
O2h Ventures
http://www.oxygenhealthcare.com/academic-in-licensing.aspx
Seeding Life Science and Technology Innovation. Licensing, Medicinal Chemistry and Investment. In-vivo Pharmacology, Toxicology and Pre-clinical. O2h is working closely with a wide range of academic groups and is active in identifying exciting basic research and spinning off exciting ideas into new companies.
O2h Ventures
http://www.oxygenhealthcare.com/in-house-programs.aspx
Seeding Life Science and Technology Innovation. Licensing, Medicinal Chemistry and Investment. In-vivo Pharmacology, Toxicology and Pre-clinical. O2h are researching frontier target classes in oncology, rare diseases and inflammation which have the potential for transformative treatments. O2h is continually evaluating frontier research and seeding in-house research programs to explore the scientific space and received grant awards to take forward the path-breaking research programs.
O2h Ventures
http://www.oxygenhealthcare.com/collaborative-discovery.aspx
Seeding Life Science and Technology Innovation. Licensing, Medicinal Chemistry and Investment. In-vivo Pharmacology, Toxicology and Pre-clinical. A collaborative approach to drug discovery enables a wider network of skills, energy and resources to come to together in which the success of the program are shared. O2h can bring to bear and invest its extensive pre-clinical capabilities, medicinal chemistry and licensing skills to share or run an end to end program or project to agreed milestones.
O2h Ventures
http://www.oxygenhealthcare.com/Default.aspx
Seeding Life Science and Technology Innovation. Licensing, Medicinal Chemistry and Investment. In-vivo Pharmacology, Toxicology and Pre-clinical. Has developed an engine for seeding a pipeline of early stage life science assets through research collaborations, in-licensing, spin-outs and investment.
TOTAL LINKS TO THIS WEBSITE
28
Webdomain
Map Your GDPR Data Instantly - GDPR Data Governance | Exonar
Map and understand your data. Instantly. Simply. At Scale . The Exonar SARlution – we make Subject Access Resquests Simple. Read more. I don’t know what we’ve got. Where do we start? Exonar maps and understands your organisation’s information, from documents to emails to databases. We use machine learning to understand the information, show where it is and who has access to it. We create a comprehensive index of everything, so any search is executed in seconds however much data you hold. The Exonar Platf...
Exonario
Definiciones y términos que no figuran en el diccionario ("Exonario" no figura en el diccionario, pero sí figura en Exonario). 191;Qué es Exonario? 191;Qué no es Exonario? Martes, 25 de febrero de 2014. Sustantivo. Del latín con. Junto, completo; pro. Juego que contiene entre sus reglas la posibilidad de continuar jugándolo una vez terminado. Aunque la definición parece complicada, en realidad es bastante fácil distinguir a un juego comproludio de aquel que no lo es. Enviar a un amigo. Cuando se expone u...
Exonate
Watch Exonate’s principal scientist, Dr Jennifer Batson interviewed for Bermuda TV. February 27, 2018. Dr Jennifer Batson presents ‘A Paradigm Shift in the Treatment of Retinal Vascular Diseases’ at Pharmacology 2017. February 27, 2018. Exonate’s principal scientist, Dr Jennifer Batson, to present at The Bermuda Principles Impact on Splicing 2nd Annual conference 2018 (BPIS). February 20, 2018. Exonate’s principal scientist, Dr Jennifer Batson, to present at Pharmacology 2017. December 13, 2017.
ExoNathan, Ça donne tout simplement envie de s'entraîner ! | Éditions Nathan
Disponible sur smartphones et tablettes.
EXO Nation | Your source for all things EXO
Your source for all things EXO! Welcome to EXO NATION! ONE OF THE MOST EXTENSIVE AND COMPLETE RESOURCES FOR EVERYTHING EXO, EXO-K, EXO-L AND EXO-M. WE ARE DEDICATED TO BRINGING THE LATEST NEWS ON THE TALENTED EXO'S. BE SURE TO CHECK OUT EVERYTHING THIS SITE HAS TO OFFER, INCLUDING THE GALLERY WHERE YOU CAN FIND A LOT OF PHOTOS. ENJOY THE SITE AND COME BACK SOON. NEW Official EXO Goods: EXO Paper Toy from SM Town! No Comments on NEW Official EXO Goods: EXO Paper Toy from SM Town! EXO Nation for SM. Please...
Bringing the Light
Wednesday, June 6, 2012. People have been visiting my blog here for info on Yashica lenses. I have modified the original post and it should now be easier to read. A full explanation of why I made the edit preceeds that post. Here is the post: http:/ exonaught.blogspot.ca/2010/09/cees-de-groots-yashicafaq.html. Sunday, December 11, 2011. New Directions, both in art and science. Which I have found quite a few little 1x1 type photography apps that I have come to love and loathe. I like the iPhone for the fr...
